-+ 0.00%
-+ 0.00%
-+ 0.00%

Keybanc Maintains Overweight on Steris, Raises Price Target to $284

Benzinga·11/06/2026 14:41:05
Diffusion vocale
Keybanc analyst Brett Fishbin maintains Steris (NYSE:STE) with a Overweight and raises the price target from $269 to $284.